WHO Pharmaceuticals Newsletter 2004, No. 03
(2004; 12 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Close this folderSAFETY OF MEDICINES
View the documentCARVEDILOL - Reports of diarrhoea
View the documentCYCLO-OXYGENASE-2 INHIBITORS - Reports of visual disturbances
View the documentFURANOCOUMARINS - Presence in a herbal preparation
View the documentLEFLUNOMIDE - Awareness and monitoring can reduce the impact of adverse effects
View the documentOXANDROLONE - Warning for interaction with warfarin
View the documentSHUBAO SLIMMING CAPSULES - Presence of fenfluramine and nitrosofenfluramine
View the documentSTATINS - Important to measure creatine kinase levels
View the documentTEGASEROD - Warning about diarrhoea and ischaemic colitis
View the documentTHIOMERSAL IN VACCINES - Recent evidence supports safety
View the documentZAFIRLUKAST - Reports of serious hepatic events
View the documentFEATURE
 

SHUBAO SLIMMING CAPSULES - Presence of fenfluramine and nitrosofenfluramine

UK. The Medicines and Healthcare products Regulatory Agency (MHRA) is alerting herbal interest groups and consumers about the presence of fenfluramine and nitrosofenfluramine in an unlicensed traditional Chinese medicine preparation, Shubao Slimming Capsules, supplied illegally as a slimming agent in the UK. Fenfluramine is an appetite suppressant and was banned globally in 1997 due to concerns about the drug's effect on the heart while nitrosofenfluramine is known to be toxic to the liver. Globally the illegal adulteration of slimming products with nitroso-fenfluramine and fenflur-amine has been associated with a large number of reports of liver toxicity. There was one report of liver failure in a patient receiving Shubao Slimming Capsules in the UK; the patient required a liver transplant. The MHRA has directed that the supply and sale of Shubao capsules should be stopped immediately and has requested cooperation from the herbal sector in minimizing the risks to consumers posed by the illegal inclusion of fenfluramine and nitroso-fenfluramine in these capsules.

Reference:

Communication to Herbal Interest Groups from MHRA, 28 April 2004. Available from URL: http://medicines.mhra.gov.uk

to previous section to next section
 

Last updated: May 3, 2013